← Back to search
ISOLA THERAPEUTICS INC
MINNEAPOLIS, MN, 55410
Unclaimed
Small Business
Source Records
No company-reported description yet. Owners can add one after claiming the profile.
Capabilities
Prime contracting experience
3 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | THE PURPOSE OF THIS AWARD IS TO ADVANCE THE DEVELOPMENT OF ISOLA'S NEBULIZATION THERAPY, A MEDICAL COUNTERMEASURE DESIGNED TO PREVENT AND TREAT PULMONARY FOAM THE INHALATION OF CHEMICAL AGENTS CAUSES. | — | $7,485,417 | Apr 27, 2026 | May 1, 2026 – Oct 31, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | PHASE I -TOPIC 431 - DRUG DELIVERY BY ENDOESOPHAGEAL LAVAGE (EEL) TO TREAT ESOPHAGEAL CANCER | — | $455,000 | Aug 30, 2024 | Sep 15, 2022 – Mar 14, 2025 |
| Prime | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | R&D FOR ENDOBRONCHIAL LAVAGE (EBL) TO PREVENT AND TREAT LUNG DAMAGE FROM PULMONARY CHEMICAL AGENTS AOI #15: REDIRECT (REPURPOSING DRUGS IN RESPONSE TO CHEMICAL THREATS) | — | $749,999 | Jun 20, 2024 | Jul 12, 2023 – Jul 11, 2025 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
No subaward records on record in current sources. Subcontract relationships are never inferred from award keywords.
Agencies supported
- Department of Health and Human ServicesGov-sourced